As of September 09, 2026, TuHURA Biosciences's top three insider holders are James A. Bianco (Chief Executive Officer, 2.17Mn shares), Anthony Scott Praill (Chief Financial Officer, 277.27K shares), Saiid Zarrabian (Head Of Strategic Partnerships, 55.50K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | James A. Bianco | Chief Executive Officer | 2,173,307 | 0 | 2,173,307 | 86.7% | 29 May, 2026 |
| 2 | Anthony Scott Praill | Chief Financial Officer | 277,273 | 0 | 277,273 | 11.1% | 03 Aug, 2022 |
| 3 | Saiid Zarrabian | Head Of Strategic Partnerships | 55,500 | 0 | 55,500 | 2.2% | 08 Dec, 2021 |
| 4 | Robert E. Hoffman | President, Ceo, And Cfo | 229 | 0 | 229 | 0.0% | 02 Jun, 2023 |
| 5 | Dennis M Brown | Chief Scientific Officer | 124 | 0 | 124 | 0.0% | 06 Jan, 2023 |
| 6 | Laura L. Johnson | Director | 2 | 0 | 2 | 0.0% | 24 Nov, 2021 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 28 May, 2026 | James A. Bianco | Chief Executive Officer | Disposed G | 150,000 | $0.00 | $0 | 2,173,307 | Direct |
| 12 Feb, 2026 | Alan List | Director | Acquired A | 156,240 | $0.00 | $0 | 156,240 | Direct |
| 12 Feb, 2026 | James S J Manuso | Director | Acquired A | 156,240 | $0.00 | $0 | 156,240 | Direct |
| 12 Feb, 2026 | George K Ng | Director | Acquired A | 156,240 | $0.00 | $0 | 156,240 | Direct |
| 12 Feb, 2026 | Robert E. Hoffman | Director | Acquired A | 156,240 | $0.00 | $0 | 156,240 | Direct |
| 12 Feb, 2026 | Craig Tendler | Director | Acquired A | 156,240 | $0.00 | $0 | 156,240 | Direct |
| 06 Jan, 2026 | Dan Dearborn | Chief Financial Officer | Acquired A | 273,696 | $0.00 | $0 | 273,696 | Direct |
| 06 Jan, 2026 | James A. Bianco | Chief Executive Officer | Acquired A | 610,332 | $0.00 | $0 | 610,332 | Direct |
| 12 Dec, 2025 | James A. Bianco | Chief Executive Officer | Acquired A | 3,414,891 | $0.00 | $0 | 3,414,891 | Direct |
| 12 Dec, 2025 | Dan Dearborn | Chief Financial Officer | Acquired A | 1,531,367 | $0.00 | $0 | 1,531,367 | Direct |
| 10 Mar, 2025 | Craig Tendler | Director | Acquired A | 151,883 | $0.00 | $0 | 151,883 | Direct |
| 02 Jan, 2025 | Alan List | Director | Acquired A | 51,275 | $0.00 | $0 | 51,275 | Direct |
| 02 Jan, 2025 | George K Ng | Director | Acquired A | 51,275 | $0.00 | $0 | 51,275 | Direct |
| 02 Jan, 2025 | James S J Manuso | Director | Acquired A | 59,590 | $0.00 | $0 | 59,590 | Direct |
| 02 Jan, 2025 | Robert E. Hoffman | Director | Acquired A | 51,275 | $0.00 | $0 | 51,275 | Direct |
| 12 Nov, 2024 | James A. Bianco | Chief Executive Officer | Acquired A | 1,065,990 | $0.00 | $0 | 1,065,990 | Direct |
| 12 Nov, 2024 | Dan Dearborn | Chief Financial Officer | Acquired A | 489,848 | $0.00 | $0 | 489,848 | Direct |
| 18 Oct, 2024 | Dennis Yamashita | Chief Scientific Officer | Acquired A | 196,790 | $0.00 | $0 | 196,790 | Direct |
| 18 Oct, 2024 | Dan Dearborn | Chief Financial Officer | Acquired A | 33,991 | $0.00 | $0 | 0 | Direct |
| 18 Oct, 2024 | Dennis Yamashita | Chief Scientific Officer | Acquired A | 196,790 | $0.00 | $0 | 196,790 | Direct |